Best Pharma sector bet in India | Indian Stocks to Make You a Millionaire
  • Recover Lost Money Plan

    A number of traders have lost their money in the market due to wrong trading advice or wrong decisions and emotions. We keep on getting a number of requests for helping these traders recover their lost money. Thus, this was the genesis of Recover Lost Money Plan. We are proud to say that till date we have helped 1290 people recover their lost money. Recover Lost Money in Market

  • Our Most Successful Intraday Tip

    Jackpot tip, as the name suggests has the potential to make you a Millionaire as it is not the number of tips one trades; but it is the accuracy of a single tip which has the potential to make you a Millionaire. This tip is a value for money for all i.e whether one can see the trading terminal or not or is dealing through a broker on phone at BSE, NSE or in Future and Options segment.
    Click on Jackpot Sure Shot Tip to know more...

Subscribe to this blog

Subscribe to full feed RSS
What is Daily Market State???
Enter your Email


Preview | Powered by FeedBlitz

Best Pharma sector bet in India

Posted By On 3:56 PM Under
1. I am bullish on Glenmark Pharmaceuticals as a company at the current valuations as stock market meltdown has provided an opportunity for one to earn quality returns. Glenmark Pharmaceuticals has 13 products in the US market and 36 ANDAs pending approval. As a net result of these efforts one can see it achieveing continous growth in the US market. One can buy this stock with a target of Rs 390 with in a time span of 12 months. One can buy this stock now to benefit from lower stock price prevailing and this is one of the best pharma sector stock at current price levels.


2. Moreover company is already on the path of takeovers with seven pharmaceutical brands in Poland from Iceland-based Actavis and its affiliate Biovena under its belt. The acquisitions help the company to get a foot hold in Poland and thus new avenues are opened for the company in new geographical areas. Moreover it will have a sale of $15 million from the seven brands for 2008-09 with a 20 per cent growth in 2009-10. Moreover it is expected to have a EPS of Rs 52 for FY09.

Most Read Content